LCDActive
Respiratory Pathogen Panel Testing
L38918
Effective: July 11, 2021
Updated: December 31, 2025
Policy Summary
Medicare Part B outpatient respiratory pathogen panel testing is covered when panels contain five or fewer respiratory pathogens, the outpatient setting can timely report results, and the result is expected to aid clinical management toward improved patient outcome. Coverage is allowed for FDA-cleared tests and laboratory-developed tests only when the laboratory documents analytical and clinical validity and clinical utility consistent with Medicare's medically reasonable and necessary standard; panels with more than five pathogens in the Part B outpatient setting are not covered.
Coverage Criteria Preview
Key requirements from the full policy
"Respiratory pathogen panel testing performed in a Part B outpatient setting (e."
Sign up to see full coverage criteria, indications, and limitations.